The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5-Independent Manner

    May 2025 in “ Experimental Dermatology
    Dorottya Ádám, József Arany, Kinga Tóth, on behalf of the Coll Cancer Richard Peto, T. Nyitrai, Balázs István Tóth, Szilárd Póliska, Christos C. Zouboulis, Attila Oláh
    Image
    Studysummary This study found that specific TRPM5 modulators are unlikely to directly affect sebaceous glands, but safe TPPO analogues may provide moderate lipogenic and anti-inflammatory effects beneficial for dry skin conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results